5.9 Monitoring, Evaluation, and Nutrition Outcomes
Key Takeaways
- Monitoring and Evaluation of Outcomes is sub-topic 3F on the CDR CSO outline, worth 6 scored items — more than Nutrition Support or Pharmaceutical Interventions individually.
- The Nutrition Care Process has four steps — assessment, diagnosis, intervention, and monitoring and evaluation — documented in ADIME format, with the diagnosis written as a PES statement.
- Monitoring and evaluation selects indicators from four outcome categories: food and nutrition-related history, anthropometric measurements, biochemical data and medical tests, and nutrition-focused physical findings.
- Serum albumin and prealbumin are negative acute-phase reactants and must not be used as markers of nutrition repletion in the presence of inflammation.
- Weekly dietitian contact during head and neck chemoradiation is associated with less weight loss and fewer treatment interruptions, making contact frequency itself a monitored outcome.
5.9 Monitoring, Evaluation, and Nutrition Outcomes
Quick Summary: CDR gives Monitoring and Evaluation of Outcomes (3F) 6 scored items — more than Nutrition Support or Pharmaceutical Interventions carry individually. Items here test whether you chose a measurable indicator, set a re-check interval matched to risk, and know which markers are meaningless in the presence of inflammation.
The Nutrition Care Process and ADIME
The Nutrition Care Process has four steps, and monitoring and evaluation is the fourth — not an optional postscript:
- Nutrition Assessment
- Nutrition Diagnosis
- Nutrition Intervention
- Nutrition Monitoring and Evaluation
Documentation follows ADIME: Assessment, Diagnosis, Intervention, Monitoring and Evaluation. The critical structural rule is that monitoring must mirror the evidence you used to make the diagnosis. If you diagnosed the problem using percentage of estimated needs and weight change, you monitor percentage of estimated needs and weight change — not a new set of variables chosen at the follow-up visit.
Writing the PES Statement
The nutrition diagnosis is written as Problem related to Etiology as evidenced by Signs and symptoms. Diagnoses fall into three domains: Intake (NI), Clinical (NC), and Behavioural-Environmental (NB).
Example: Inadequate oral intake (problem) related to chemoradiation-induced Grade 3 oral mucositis and odynophagia (etiology) as evidenced by 3-day intake averaging 35% of estimated energy needs for 10 days and 6% unintentional weight loss in 1 month (signs and symptoms).
Two rules decide most exam items. The etiology must be something an intervention can act on — writing "related to cancer" gives you nothing to treat, whereas "related to mucositis-associated odynophagia" points at analgesia, texture modification, and enteral access. And the signs and symptoms must be measurable, because they become the monitoring indicators.
Indicators, Criteria, and the Four Outcome Categories
An indicator is what you measure; a criterion is the goal you compare it against. "Weight" is an indicator; "regain 2 kg within 6 weeks" is a criterion.
Indicators are selected from four categories:
| Category | Oncology examples |
|---|---|
| Food and nutrition-related history | Percentage of estimated energy and protein needs met; oral supplement adherence; enzyme doses actually taken per meal; symptom scores |
| Anthropometric measurements | Weight and percentage change; body mass index; mid-arm muscle circumference; skeletal muscle index at the third lumbar vertebra on serial CT |
| Biochemical data, medical tests, and procedures | Electrolytes; phosphate, potassium and magnesium in refeeding risk; glucose on corticosteroids; triglycerides and liver function on parenteral nutrition; fecal elastase-1 response |
| Nutrition-focused physical findings | Temporal and clavicular wasting; oedema and ascites; handgrip strength by dynamometry; oral mucosal condition |
Setting the Monitoring Interval
| Situation | Reassessment interval |
|---|---|
| Inpatient, high nutrition risk or on nutrition support | Every 2-3 days, and daily during refeeding risk |
| Refeeding syndrome risk | Phosphate, potassium and magnesium at least every 12-24 hours for the first 72 hours |
| New parenteral nutrition | Electrolytes, glucose and triglycerides daily until stable, then weekly; liver function weekly |
| Head and neck chemoradiation | Weekly throughout the course and for several weeks after |
| Outpatient on cyclical chemotherapy | Each treatment cycle, timed to the same cycle day for comparability |
| Stable survivorship | Every 3-6 months, or with any new symptom or 5% weight change |
The head and neck interval is evidence-based rather than conventional: intensive weekly dietetic contact during radiotherapy and chemoradiation is associated with less weight loss, fewer unplanned treatment interruptions, and better quality of life than ad hoc referral. On this exam, "refer back if problems develop" is almost never the right answer for a patient undergoing head and neck chemoradiation.
What to Monitor, and What Not To
Reliable indicators of nutrition change: weight trend interpreted against fluid status, percentage of estimated needs met, PG-SGA rescored serially, handgrip strength, muscle mass on serial imaging where CT is already being done for staging, symptom burden, and functional and quality-of-life measures.
Unreliable indicators: serum albumin and prealbumin are negative acute-phase reactants. In systemic inflammation — which is the norm in active malignancy — they fall regardless of nutrition intake and rise as inflammation resolves regardless of feeding. They do not track repletion, and using them to judge whether nutrition support is "working" is a standing exam trap. A single weight is similarly unreliable in the presence of ascites, oedema, or large-volume hydration; trend and fluid context are what carry meaning.
Therapy-Specific Monitoring
- Enteral nutrition: volume actually delivered versus prescribed (interruptions for procedures are the usual reason for the gap), tolerance by symptoms, tube-site condition, hydration and flush delivery, and blood glucose. Routine gastric residual volume measurement is not recommended as a standalone reason to hold feeds.
- Parenteral nutrition: glucose and electrolytes, triglycerides, liver function, catheter site and fever surveillance, fluid balance, and continual reassessment of whether the gut has recovered enough to wean.
- Pancreatic enzyme replacement: stool frequency and consistency, steatorrhoea, weight, fat-soluble vitamin status, and whether the patient is taking the enzyme with food at the prescribed dose — non-adherence, not dose inadequacy, is the more common cause of apparent failure.
- Corticosteroid exposure: glucose, fluid retention, and muscle mass over time.
Evaluating, Then Revising
Compare indicator to criterion and classify the outcome: goal met, progressing, or not progressing. Then act on the classification.
Worked example. Two weeks after starting nocturnal jejunal feeds, a head and neck patient's intake has risen from 35% to 88% of estimated needs, weight is stable at 61 kg, and handgrip has improved from 22 to 25 kg. Intake and function are progressing while weight is only stable — appropriate at this stage, because arresting loss precedes regain. The plan continues, and the criterion for the next interval becomes weight gain.
Had intake stayed at 40% because feeds were repeatedly held for procedures, the correct response is not to raise the prescribed rate but to fix the delivery problem and consider compensatory or catch-up scheduling. Resolve the nutrition diagnosis when the evidence for it disappears, and write a new one when the etiology changes — for example, from mucositis-related inadequate intake during treatment to altered gastrointestinal function after surgery.
Outcomes at the Programme Level
Specialists are increasingly expected to report aggregate outcomes: malnutrition diagnosis capture rate, time from referral to dietitian contact, proportion of head and neck patients losing 5% or more of body weight during radiation, unplanned treatment breaks, and readmission rates among patients discharged on home nutrition support. These metrics justify staffing and are the practice-level expression of the same monitoring discipline applied to one patient.
Ten days after starting enteral nutrition, a patient's serum albumin has not risen despite meeting 90% of estimated energy and protein needs. C-reactive protein remains elevated at 62 mg/L. What is the correct interpretation?
Which PES statement is best constructed for nutrition monitoring and evaluation?
A patient beginning definitive chemoradiation for oropharyngeal cancer is seen at baseline. What monitoring interval is best supported by the evidence?
A hospitalised patient on enteral nutrition is meeting only 45% of the prescribed volume because feeds are repeatedly held for imaging and procedures. Weight continues to fall. What is the most appropriate monitoring-driven response?